It is controversial whether long-term anticholinergic therapy (AC-T) can cause short-term memorydisturbance, long-term memorydisturbance or intelligence impairment. Ninety patients with Parkinson's disease were examined prospectively to clarify the existence of memory and intelligence impairment induced by long-term AC-T. Neuropsychological tests detected eight patients with at least one of four types of deficits; intelligence impairment in four patients, verbal delayed recall impairment in eight, verbal short-term memorydisturbance in five, and verbal longterm memorydisturbance in six. Two types of verbal memorydisturbance (short-term one and long-term one) appeared with double dissociation, suggesting that there may be an independence between the two types of verbal memorysystem. Older patients were more prone to suffer from these reversible deficits. Moreover, all of the patients who resumed AC-T, showed recurrence of the deficits acutely. These observations should indicate the tight relation between long-term AC-T and neuropsychological deficits. (Internal Medicine 37: 514-518, 1998) 
Introduction
Some studies showed that long-term anticholinergic (AC) therapy can occasionally cause memory disturbance (1-3), while another study showed that it can cause intelligence impairment (4). It is controversial whether long-term AC therapy can cause short-term memory disturbance, long-term memory disturbance, intelligence impairment, or a combination. It is also not clear whether or not older patients are more likely to develop the neuropsychological deficits such as memory disturbance or intelligence impairment. Furthermore, there have been no detailed studies concerning the effect of cessation and resumption of AC therapy on those suffering from therapyinduced memory disturbance or intelligence impairment. To clarify the above three points, we prospectively investigated patients with Parkinson's disease (PD) whom we had treated with AC therapy.
For editorial comment, see p 493.
Methods
Our prospective study was conducted on 90 patients with PD who had been followed in our departments (Japanese Red Cross Medical Center and National Tokyo Hospital) for the previous twenty months. The patients gave informed-consent to our study. They had been treated with AC therapy, and showed no acute side effects of the therapy. Their age ranged from 35 to 92 years (mean; 55.9, S.D.; 13.4). The patients had been followedup by three neurologists.
All of the 90 patients investigated in our study did not show hallucination, delirium or consciousness disturbance. Detailed neuropsychological tests [the Wechsler Adult Intelligence Scale (WAIS) (5) and the Wechsler Memory Scale-Revised (WMS-R) (6)] were administered to the patients who had clinically shown neuropsychological deficits. Performance IQ (PIQ) and visual memory index are strongly influenced by motor impairment, because their subtests include action and mobility.
Since the patients examined in this study suffered from motor impairment induced by PD, we did not use PIQ and visual memory subtests for the evaluation of intelli-gence and memory.In this report, intelligence impairment was defined as the condition that the reduction of verbal IQ (VIQ) in the WAIS (the Japanese edition) was morethan 15 points. We conducted the WMS-R(the Japanese edition; standardization in progress) in totally 1 1 2 normal healthy volunteers, consisting of three age range groups (age 55-64, age 65-74 and age 75-84), in order to obtain average ± S.D. values in each subtest of the WMS-R. Wedefined that memorydisturbance was induced by long-term AC therapy, when the score of each memory subtest wasreduced by more than one S.D. during the long-term AC therapy. Weinvestigated digit span for short-term memory, verbal paired associates I and logic memoryI for verbal longterm memory,and verbal paired associates II and logic memory II for delayed recall.
Somepatients wished to resume AC therapy after a certain period, since they suffered from regressing akinesia, resting tremor or rigidity. After they were informed of the possibility that AC therapy could cause a relapse of neuropsychological dysfunction, they consented to resumption of AC therapy. This group is called the Resumption Group. The rest of the patients, who had shown neuropsychological dysfunction, and managed to get along without resumption of AC therapy. This group will be called the Non-resumption Group in this study.
The WAIS and WMS-Rwerefirst administered during the first long-term AC therapy. Immediately after these tests, we terminated their AC therapy, but did not modify their other drugs in any way. They had not taken any drugs which could influence memoryor intelligence.
Their anti-Parkinson agent therapy is summarized in Table 1 . Their neurological symptoms and signs were carefully followed up and the same neuropsychological tests were administered the second time at four weeks after the cessation of long-term AC therapy. The third WAIS and WMS-R were conducted four weeks after the resumption of AC therapy in all members of the Resumption Group. In the Non-resumption Group, we administered the same tests for the third time about 6 months after the cessation of AC therapy. Electroencephalogram (EEG), brain computed tomography (CT) and cranial magnetic resonance imaging (MRI) (1.0 or 1.5 Tesla) were conducted in all the patients during AC therapy and at four weeks after its cessation.
Results
Among the 90 PD patients, we found eight (9%) (five males and three females) suffering from characteristic neuropsychological deficits. The results of the WAIS are given in The left numbers in parentheses are the differences between the second trial and first trial. The right numbers are those between the second trial and third trial. The data outside of the parentheses in the column of verbal IQ are the IQ data obtained during the initial AC therapy. The data outside of the parentheses in the other columns than verbal IQ are the raw scores obtained during the initial AC therapy. are also given in Table 2 . Verbal short-term memory disturbance was present in five patients (Pts. 1, 2, 3, 4 and 5). Verbal memory index subtests (verbal paired associates I and logical memory I) were involved in six of the eight patients (Pts. 1, 3, 4, 5, 6 and 8) , showing that verbal long-term memory disturbance was present in those six patients.
Delayed recall index consists of verbal delayed recall subtests and visual delayed recall subtests. Since visual delayed recall subtests include motor task and can be influenced by motor disability ofPD, we used only verbal delayed recall subtests for the evaluation of delayed recall and found that it was also involved in all eight. In the Resumption Group, many scores of memory subtests were re-decreased after the resumption of the therapy. In contrast, in the Non-resumption Group, none of the memory s ubtest scores changed significantly after long-term follow-up. Four patients (Pts. 1, 3, 4 and 5) suffered from both verbal short-term and long-term memory disturbance.
On the contrary, one patient (Pt. 2) had verbal short-term memory disturbance without verbal long-term memory disturbance and two (Pts. 6 and 8) had verbal long-term memory disturbance without verbal short-term memory disturbance.
These observations showed that there is a double dissociation between verbal shortterm memorydisturbance and verbal long-term memory disturbance. Moreover, most of the attention index, verbal memoryindex and VIQ reached the normal range, that was greater than average minus one S.D. for attention index and verbal memory index, and more than 85 points for VIQ, after the cessation of AC therapy in all eight patients (data not shown). These results from neuropsychological examinations led us to the conclusion that all eight suffered from little or no memorydisturbance or intelligence impairment when they were not treated with AC therapy. These deficits occurred gradually, and they had no evocative factors such as infection, dehydration or cerebrovascular disease. Their ages ranged from 59 to 81 years. Their average age (68.6 years old) was higher than that of the overall population that received AC treatment (55.9 years old) (t test; t=2.64: p<0.02), while the dose of AC was approximately similar between the patients with or without neuropsychological dysfunction. Therefore,the relation between number of patients with the neuropsychological deficits and age was analyzed statistically. Among90 patients, 82 patients (younger than 58 years old; 55 patients, older than 59 years old; 27 patients) did not have memorydisturbance or intelligence impairment, and eight patients, all of whom were older than 59 years old, Five patients had a poor understanding. Some patients had character change, abnormal behavior, perseveration and lack of vigor. All these clinical symptoms disappeared reversibly within a few weeks after the cessation of long-term AC therapy with the exception of one patient (Pt. 7) who showed perseveration. None had hallucinations, akathisia, or focal neuropsychologic al deficit except for memory disturbance. Four out of the eight patients (Pts. 1, 2, 3 and 4) resumed AC therapy from one to three months after their cessation of AC therapy. The rest (Pts. 5, 6, 7 and 8) consisted of the Nonresumption Group. All four patients of the Resumption Group suffered from memory disturbance and/or intelligence impairment again after the second AC therapy. Most of the symptoms, which the patients of Resumption Group had suffered from during initial AC therapy, reappeared by a few weeks after the resumption of the therapy (Tables  1, 4 In this report, 90 patients suffering from PD with long-term AC therapy were prospectively investigated to shed light on these points. The present study showed that long-term AC therapy can cause memory disturbance and/or intelligence 
M.D.: memory disturbance, C.C.: character change, A.B.: abnormal behavior, P.U.: poor understanding, L.V.: lack of vigor, P.: perseveration. 1 st: during the first AC therapy, 2nd: fourweeks afterthe cessationofAC therapy, 3rd: aftertheresumption of AC therapy in Resumption Group, and after a long-term follow-up in Non-resumption Group.
Internal Medicine Vol.
37, No. 6 (June 1998) impairment. We consider that all eight patients did not suffer from consciousness disturbance, because of their good scores in orientation questions in the WMS-R and normal results in EEG. Concerning the relation between memory subtypes, a double dissociation was present between verbal short-term memory disturbance and verbal long-term memory disturbance. Though there are few studies reporting memory dissociation in PD ( 14), our data have proved that verbal short-term memory and verbal long-term memory could be disturbed, with double dissociation, by AC therapy in PD, suggesting that these two types of memory system are mutually independent.
Visual short-term memory, visual long-term memory and performance intelligence were not investigated in this study, because deteriorated motor disability induced by the cessation of AC therapy can easily influence the memory index and performance IQ. There is the possibility that not only verbal deficits, but also visual deficits in the WAIS and the WMS-R are induced by long-term AC therapy.
One of the factors in the pathogenesis of Alzheimer's disease, which also leads to dementia, is the reduction in levels of some types of neurotransmitters, including acetylcholine (15, 16) . Moreover, blockade of the cholinergic system is known to bring about cognitive dysfunction including verbal amnesia ( 17, 1 8). However, detailed localization responsible for verbal memory dysfunction has not been clear, and neither has the issue of short-term and long-term memory dysfunction. Our large-scale study clearly showed that short-term verbal memory and long-term verbal memory can be impaired by blockade of the cholinergic system with mutual independence, although the reason for the dissociation between those two dysfunctions remains to be resolved. According to a report, normal elderly subjects were more susceptible to memory disturbance than younger subjects on the condition of short-term massive AC administration (9). However, it is not clear whether age is a factor in the chronic and reversible side effects of long-term AC therapy. The present study indicated that older patients are at a greater risk to develop memory disturbance and/or intelligence impairment.
AC therapy was resumed in those who had shown severe deterioration of motor inability. Patients resuming AC therapy tended to suffer from recurrence of memory disturbance and/or intelligence impairment, however, the statistical analysis was not appropriate due to the small number of the subjects. We believe that patients with reversible chronic-onset memory disturbance and/or intelligence impairment induced by AC therapy are more likely to show acute-onset memory disturbance and/or intelligence impairment after the resumption of the same therapy. We may speculate that the mechanism of their memory disturbance and/or intelligence impairment is a decline in the capacity of the cholinergic nervous system. When aging reduces the capacity of their cholinergic nervous system to a certain threshold level, memory disturbance or intelligence impairment could become clinically evident. This study has shed light on the relation between the cholinergic nervous system and neuropsychological deficits, demonstrating the induction of reversible memory disturbance and 
